Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening.
Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening.
复制标题
III型粘二糖的亲属对孕入疗法筛查的态度。
DOI:
10.1038/s41431-020-0648-2
复制
发表时间:
2020-10
期刊:
影响因子:
--
通讯作者:
Haverman L
中科院分区:
文献类型:
--
作者:
Nijmeijer SCM;Conijn T;Lakeman P;Henneman L;Wijburg FA;Haverman L
Preconception expanded carrier screening (ECS) aims to detect carrier couples of autosomal recessive (AR) disorders before pregnancy in order to increase reproductive autonomy of prospective parents. Genetic knowledge and knowledge gained from experience influence decision making on participation in genetic testing and understanding carrier test results. In this study we assessed whether parents and relatives of patients with the severe AR condition mucopolysaccharidosis type III (MPS III), who are expected to have genetic and experiential knowledge, have more positive attitudes toward ECS than the Dutch reference group. Parents of all MPS III patients known to the Dutch expert center were invited to participate and asked to invite first and second degree relatives. The online questionnaire started with an educational text, and assessed attitudes toward ECS, genetic knowledge and perceived MPS III severity. Results were compared with the Dutch population. Parents and relatives of MPS III patients (n = 159) scored higher on the genetic knowledge test and perceived MPS III as more severe compared with the general Dutch population (n = 781). Parents and relatives reported to be more likely to participate in ECS (84.3% and 62.5%, respectively) compared with the public (31%) (p < 0.001). Being a relative of a MPS III patient was the strongest variable in the regression analyses for intended ECS participation. Our results show that genetic knowledge influences ECS decision making. Therefore, appropriate information on ECS and genetic counseling is needed to enable prospective parents from the general population, including relatives of patients with severe hereditary disorders, to make informed decisions.
登录
查看更多内容
DOI:
10.1038/ejhg.2016.43
发表时间:
2016-10
期刊:
European journal of human genetics : EJHG
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1089/gte.2007.0057
发表时间:
2008-03-01
期刊:
GENETIC TESTING
影响因子:
--
作者:
Etchegary, Holly;Potter, Beth;Wilson, Brenda
通讯作者:
Wilson, Brenda
DOI:
10.1089/gte.2004.8.80
发表时间:
2004-06-01
期刊:
GENETIC TESTING
影响因子:
--
作者:
Poppelaars, FAM;Henneman, L;Ten Kate, LP
通讯作者:
Ten Kate, LP
影响因子:
--
作者:
Conijn, Thirsa;Nijmeijer, Stephanie C M;Haverman, Lotte
通讯作者:
Haverman, Lotte
DOI:
10.1038/ejhg.2015.271
发表时间:
2016-06
期刊:
European journal of human genetics : EJHG
影响因子:
--
作者:
Henneman L;Borry P;Chokoshvili D;Cornel MC;van El CG;Forzano F;Hall A;Howard HC;Janssens S;Kayserili H;Lakeman P;Lucassen A;Metcalfe SA;Vidmar L;de Wert G;Dondorp WJ;Peterlin B
通讯作者:
Peterlin B